MHC matching and mechanisms of alloactivation in corneal transplantation

Transplantation

Volumn 72, Issue 9, 2001, Pages 1491-1497

  Nicholls, Susan M ^a,b   Williams, Neil A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DEPLETION; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; T LYMPHOCYTE ACTIVATION;

EID: 0035890884     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200111150-00004     Document Type: Article

References (35)

1. Histocompatibility antigen and passenger cell content of normal and diseased human cornea
2. Association between corneal allograft reactions and HLA compatibility
3. The Collaborative Corneal Transplantation Studies (CTTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation
4. Conclusions of the corneal transplant follow up study
5. HLA-DR/RFLP compatible corneal grafts
6. Beneficial effect of HLA-DR matching on the survival of corneal allografts
7. Non-HLA antigens and HLA-DR matching in corneal transplantation
8. Non-MHC antigens and their relative resistance to immunosuppression after corneal transplantation
9. Effect of mismatches for major his tocompatibility complex and minor antigens on corneal graft rejection
10. Orthotopic corneal transplantation in mice evidence that the immunogenetic rules of rejection do not apply
11. Characterization of cell mediated immune responses elicited by orthotopic corneal allografts in mice
12. Corneal transplantation-immunologically privileged status
13. Class I disparate corneal grafts enjoy afferent but not efferent blockade of the immune response
14. Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression
15. Major histocompatibility complex class I presentation of exogenously acquired minor alloantigens initiate skin allograft rejection
16. Corneal allografts fail to express la antigens
17. The differential effect of donor versus host Langerhans cells in the rejection of MHC matched corneal allografts
18. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: Evidence that graft antigens are recognised exclusively via the "indirect" pathway
19. The expression of HLA antigens by cells of the human cornea
20. Lymphocytes and Langerhans cells in the normal human cornea
21. The expression of major histocompatibility complex and leukocyte antigens by cells in the rat cornea
22. Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies
23. A pure class II MHC disparity does not induce rejection of cornea or heart grafts in the rat
24. On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo
25. Characteristics of rejection of orthotopic corneal allografts in the rat
26. T-cell mediated responses in a murine model of orthotopic corneal transplantation
27. Role of donor-specific cytotoxic T cells in normal and high-risk eyes
28. Corneal allograft rejection
29. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection
30. Indirect T cell allorecognition contributes to the rejection of vascularised kidney allografts
31. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution
32. The role of human minor histocompatibility antigens in graft failure: A mini-review
33. Immunogenetics of human minor histocompatibility antigens: Their polymorphisms and immunodominance
34. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: The H60 histocompatibility antigen dominates over all others
35. Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation